Using Machine Learning to Predict the Duration of Atrial Fibrillation: Model Development and Validation

BackgroundAtrial fibrillation (AF) is a progressive disease, and its clinical type is classified according to the AF duration: paroxysmal AF, persistent AF (PeAF; AF duration of less than 1 year), and long-standing persistent AF (AF duration of more than 1 year). When conside...

Full description

Saved in:
Bibliographic Details
Main Authors: Satoshi Shimoo, Keitaro Senoo, Taku Okawa, Kohei Kawai, Masahiro Makino, Jun Munakata, Nobunari Tomura, Hibiki Iwakoshi, Tetsuro Nishimura, Hirokazu Shiraishi, Keiji Inoue, Satoaki Matoba
Format: Article
Language:English
Published: JMIR Publications 2024-11-01
Series:JMIR Medical Informatics
Online Access:https://medinform.jmir.org/2024/1/e63795
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846159806986977280
author Satoshi Shimoo
Keitaro Senoo
Taku Okawa
Kohei Kawai
Masahiro Makino
Jun Munakata
Nobunari Tomura
Hibiki Iwakoshi
Tetsuro Nishimura
Hirokazu Shiraishi
Keiji Inoue
Satoaki Matoba
author_facet Satoshi Shimoo
Keitaro Senoo
Taku Okawa
Kohei Kawai
Masahiro Makino
Jun Munakata
Nobunari Tomura
Hibiki Iwakoshi
Tetsuro Nishimura
Hirokazu Shiraishi
Keiji Inoue
Satoaki Matoba
author_sort Satoshi Shimoo
collection DOAJ
description BackgroundAtrial fibrillation (AF) is a progressive disease, and its clinical type is classified according to the AF duration: paroxysmal AF, persistent AF (PeAF; AF duration of less than 1 year), and long-standing persistent AF (AF duration of more than 1 year). When considering the indication for catheter ablation, having a long AF duration is considered a risk factor for recurrence, and therefore, the duration of AF is an important factor in determining the treatment strategy for PeAF. ObjectiveThis study aims to improve the accuracy of the cardiologists’ diagnosis of the AF duration, and the steps to achieve this goal are to develop a predictive model of the AF duration and validate the support performance of the prediction model. MethodsThe study included 272 patients with PeAF (aged 20-90 years), with data obtained between January 1, 2015, and December 31, 2023. Of those, 189 (69.5%) were included in the study, excluding 83 (30.5%) who met the exclusion criteria. Of the 189 patients included, 145 (76.7%) were used as training data to build the machine learning (ML) model and 44 (23.3%) were used as test data for predictive ability of the ML model. Using a questionnaire, 10 cardiologists (group A) evaluated whether the test data (44 patients) included AF of more than a 1-year duration (phase 1). Next, the same questionnaire was performed again after providing the ML model’s answer (phase 2). Subsequently, another 10 cardiologists (group B) were shown the test results of group A, were made aware of the limitations of their own diagnostic abilities, and were then administered the same 2-stage test as group A. ResultsThe prediction results with the ML model using the test data provided 81.8% accuracy (72% sensitivity and 89% specificity). The mean percentage of correct answers in group A was 63.9% (SD 9.6%) for phase 1 and improved to 71.6% (SD 9.3%) for phase 2 (P=.01). The mean percentage of correct answers in group B was 59.8% (SD 5.3%) for phase 1 and improved to 68.2% (SD 5.9%) for phase 2 (P=.007). The mean percentage of answers that differed from the ML model’s prediction for phase 2 (percentage of answers where cardiologists did not trust the ML model and believed their own determination) was 17.3% (SD 10.3%) in group A and 20.9% (SD 5%) in group B and was not significantly different (P=.85). ConclusionsML models predicting AF duration improved the diagnostic ability of cardiologists. However, cardiologists did not entirely rely on the ML model’s prediction, even if they were aware of their diagnostic capability limitations.
format Article
id doaj-art-39d75f31a9c449a6b312b2f59f3e5abd
institution Kabale University
issn 2291-9694
language English
publishDate 2024-11-01
publisher JMIR Publications
record_format Article
series JMIR Medical Informatics
spelling doaj-art-39d75f31a9c449a6b312b2f59f3e5abd2024-11-22T21:33:25ZengJMIR PublicationsJMIR Medical Informatics2291-96942024-11-0112e6379510.2196/63795Using Machine Learning to Predict the Duration of Atrial Fibrillation: Model Development and ValidationSatoshi Shimoohttps://orcid.org/0000-0001-6868-2827Keitaro Senoohttps://orcid.org/0000-0002-8597-7165Taku Okawahttps://orcid.org/0009-0003-2671-6330Kohei Kawaihttps://orcid.org/0009-0009-8885-2446Masahiro Makinohttps://orcid.org/0009-0001-2048-5020Jun Munakatahttps://orcid.org/0009-0002-3070-8010Nobunari Tomurahttps://orcid.org/0000-0002-0045-8631Hibiki Iwakoshihttps://orcid.org/0000-0002-4680-9388Tetsuro Nishimurahttps://orcid.org/0000-0003-2235-4064Hirokazu Shiraishihttps://orcid.org/0000-0002-2421-3647Keiji Inouehttps://orcid.org/0000-0001-5321-2216Satoaki Matobahttps://orcid.org/0000-0002-9373-4331 BackgroundAtrial fibrillation (AF) is a progressive disease, and its clinical type is classified according to the AF duration: paroxysmal AF, persistent AF (PeAF; AF duration of less than 1 year), and long-standing persistent AF (AF duration of more than 1 year). When considering the indication for catheter ablation, having a long AF duration is considered a risk factor for recurrence, and therefore, the duration of AF is an important factor in determining the treatment strategy for PeAF. ObjectiveThis study aims to improve the accuracy of the cardiologists’ diagnosis of the AF duration, and the steps to achieve this goal are to develop a predictive model of the AF duration and validate the support performance of the prediction model. MethodsThe study included 272 patients with PeAF (aged 20-90 years), with data obtained between January 1, 2015, and December 31, 2023. Of those, 189 (69.5%) were included in the study, excluding 83 (30.5%) who met the exclusion criteria. Of the 189 patients included, 145 (76.7%) were used as training data to build the machine learning (ML) model and 44 (23.3%) were used as test data for predictive ability of the ML model. Using a questionnaire, 10 cardiologists (group A) evaluated whether the test data (44 patients) included AF of more than a 1-year duration (phase 1). Next, the same questionnaire was performed again after providing the ML model’s answer (phase 2). Subsequently, another 10 cardiologists (group B) were shown the test results of group A, were made aware of the limitations of their own diagnostic abilities, and were then administered the same 2-stage test as group A. ResultsThe prediction results with the ML model using the test data provided 81.8% accuracy (72% sensitivity and 89% specificity). The mean percentage of correct answers in group A was 63.9% (SD 9.6%) for phase 1 and improved to 71.6% (SD 9.3%) for phase 2 (P=.01). The mean percentage of correct answers in group B was 59.8% (SD 5.3%) for phase 1 and improved to 68.2% (SD 5.9%) for phase 2 (P=.007). The mean percentage of answers that differed from the ML model’s prediction for phase 2 (percentage of answers where cardiologists did not trust the ML model and believed their own determination) was 17.3% (SD 10.3%) in group A and 20.9% (SD 5%) in group B and was not significantly different (P=.85). ConclusionsML models predicting AF duration improved the diagnostic ability of cardiologists. However, cardiologists did not entirely rely on the ML model’s prediction, even if they were aware of their diagnostic capability limitations.https://medinform.jmir.org/2024/1/e63795
spellingShingle Satoshi Shimoo
Keitaro Senoo
Taku Okawa
Kohei Kawai
Masahiro Makino
Jun Munakata
Nobunari Tomura
Hibiki Iwakoshi
Tetsuro Nishimura
Hirokazu Shiraishi
Keiji Inoue
Satoaki Matoba
Using Machine Learning to Predict the Duration of Atrial Fibrillation: Model Development and Validation
JMIR Medical Informatics
title Using Machine Learning to Predict the Duration of Atrial Fibrillation: Model Development and Validation
title_full Using Machine Learning to Predict the Duration of Atrial Fibrillation: Model Development and Validation
title_fullStr Using Machine Learning to Predict the Duration of Atrial Fibrillation: Model Development and Validation
title_full_unstemmed Using Machine Learning to Predict the Duration of Atrial Fibrillation: Model Development and Validation
title_short Using Machine Learning to Predict the Duration of Atrial Fibrillation: Model Development and Validation
title_sort using machine learning to predict the duration of atrial fibrillation model development and validation
url https://medinform.jmir.org/2024/1/e63795
work_keys_str_mv AT satoshishimoo usingmachinelearningtopredictthedurationofatrialfibrillationmodeldevelopmentandvalidation
AT keitarosenoo usingmachinelearningtopredictthedurationofatrialfibrillationmodeldevelopmentandvalidation
AT takuokawa usingmachinelearningtopredictthedurationofatrialfibrillationmodeldevelopmentandvalidation
AT koheikawai usingmachinelearningtopredictthedurationofatrialfibrillationmodeldevelopmentandvalidation
AT masahiromakino usingmachinelearningtopredictthedurationofatrialfibrillationmodeldevelopmentandvalidation
AT junmunakata usingmachinelearningtopredictthedurationofatrialfibrillationmodeldevelopmentandvalidation
AT nobunaritomura usingmachinelearningtopredictthedurationofatrialfibrillationmodeldevelopmentandvalidation
AT hibikiiwakoshi usingmachinelearningtopredictthedurationofatrialfibrillationmodeldevelopmentandvalidation
AT tetsuronishimura usingmachinelearningtopredictthedurationofatrialfibrillationmodeldevelopmentandvalidation
AT hirokazushiraishi usingmachinelearningtopredictthedurationofatrialfibrillationmodeldevelopmentandvalidation
AT keijiinoue usingmachinelearningtopredictthedurationofatrialfibrillationmodeldevelopmentandvalidation
AT satoakimatoba usingmachinelearningtopredictthedurationofatrialfibrillationmodeldevelopmentandvalidation